RSS feed source: National Institute of Health
Notice of Informational Webinar for RFA-EY-25-002 Advancing Vision Health Equity through Multi-level Interventions and Community-Engaged Research (R01 – Clinical Trial Optional)
This notice is to inform potential applicants for the Advancing Vision Health Equity through Multi-level Interventions and Community-Engaged Research (R01 – Clinical Trial Optional; RFA-EY-25-002) funding opportunity that NEI and NIMHD will hold an informational webinar on February 7, 2025, at 2:30 PM Eastern Standard Time (US and Canada). The purpose of this RFA is to request applications that aim to implement and evaluate multi-level interventions and community engaged research to advance vision equity. During the webinar, NEI and NIMHD staff will explain the goals and objectives of the notice of funding opportunity (NOFO) and answer questions from attendees.
All prospective applicants are invited to attend the webinar. Participants are encouraged to submit their questions in advance
Click this link to continue reading the article on the source website.
RSS feed source: National Institute of Health
Notice of Information: Reissuance of Notices of Funding Opportunity (NOFO) Global Brain and Nervous System Disorders Research Across the Lifespan (R01, R21)
This notice is to inform the research community that the Fogarty International Center (FIC) intends to issue notices of funding opportunities (NOFOs) to solicit applications for its Global Brain and Nervous System Disorders Research Across the Lifespan (Global Brain) Program.
These NOFOs are intended to be reissuances of the now expired PAR-22-097 (R01 Clinical Trial Optional) and PAR-22-098 (R21 Clinical Trial Optional), along with companion funding opportunities that disallow clinical trials (R01 Clinical Trial Not Allowed and R21 Clinical Trial Not Allowed). All participating NIH institutes, centers, and offices will be clearly identified and designated on the published NOFOs.
This notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications. The NOFOs are anticipated to be
Click this link to continue reading the article on the source website.
RSS feed source: National Institute of Health
Participating Organization(s)
National Institutes of Health (NIH)
Components of Participating Organizations
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Office of The Director, National Institutes of Health (OD)
Funding Opportunity Title
New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed)
Activity Code
R03 Small Grant Program
Announcement Type
Related Notices
April 4, 2024 – Overview of Grant Application and Review Changes for Due Dates on or after January 25, 2025. See Notice NOT-OD-24-084.August 31, 2022– Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.August 5, 2022– Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.
Click this link to continue reading the article on the source website.
RSS feed source: National Institute of Health
Notice of Intent to Publish a Funding Opportunity Announcement for NICHD Program Project Grants for HIV Research (P01 Clinical Trial Optional)
Background
The mission of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is to lead research and training to understand human development, improve reproductive health, enhance the lives of children and adolescents, and optimize abilities for all. NICHD supports and conducts domestic and international research and NIH research training and career development programs related to the epidemiology, diagnosis, clinical manifestations, pathogenesis, transmission, treatment, and prevention of HIV infection and its complications in infants, children, adolescents, and women (including pregnant and lactating). In all studies the inclusion of populations disproportionately affected by incidence and prevalence of HIV including racial and ethnic minority groups is expected.
NICHD wants to strengthen both existing collaborations and foster
Click this link to continue reading the article on the source website.